Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability

Neuroradiology Journal

Volumn 26, Issue 1, 2013, Pages 3-17

  Temel, S ^a   Kekliǧkoǧlu, Hava Donmez ^a   Vural, G ^a   Deniz, O ^a   Ercan, K ^a  

^a YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Apparent diffusion coefficient; Diffusion tensor magnetic resonance imaging; Fractional anisotropy; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; CEREBELLAR PEDUNCLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; DIFFUSION TENSOR IMAGING; EXPANDED DISABILITY STATUS SCALE; FEMALE; FRACTIONAL ANISOTROPY; FUNCTIONAL NEUROIMAGING; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; QUANTITATIVE ANALYSIS; WHITE MATTER;

EID: 84876402468     PISSN: 19714009     EISSN: None     Source Type: Journal    
DOI: 10.1177/197140091302600101     Document Type: Article

References (55)

1. Siva A. The spectrum of multiple sclerosis and treatment decisions. Clin Neurol Neurosurg. 2006; 108: 333-338.
2. Miller DH, Grossman RI, Reingolt SC, et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain. 1998; 121: 3-24. (Pubitemid 28045503)
3. Ferguson B, Matyszak MK, Esiri MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain. 1997; 120: 393-399. (Pubitemid 27153632)
4. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis. Ann Neurol. 2001; 50: 121-127.
5. Wayne Moore GR. MRI-clinical correlations: more than inflammation alone-What can MRI contribute to improve the understanding of pathological processes in MS? J Neurol Sci. 2003; 206: 175-179. (Pubitemid 36143724)
6. Brex PA, Ciceralli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med. 2002; 346: 158-164. (Pubitemid 34438881)
7. Kappo L, Moeri D, Radue EW, et al. Predictive value of gadolinium-enhancent magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta analysis Group. Lancet. 1999; 353: 964-969. (Pubitemid 29132605)
8. Ge Y, Law M, Grossman RI. Applications of diffusion tensor MR imaging in multiple sclerosis. Ann N Y Acad Sci. 2005; 1064: 202-219. (Pubitemid 43030959)
9. Sarchielli P, Presciutti O, Pelliccioli GP, et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain. 1999; 122: 513-521. (Pubitemid 29110525)
10. Freedman MS. Multiple Sclerosis and Demyelinating Diseases Advances in Neurology. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 111-185.
11. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal appearing white matter in multiple sclerosis. Neurology. 1995; 45: 478-82.
12. Miller DH, Thompson AJ, Filippi M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol. 2003; 250: 1407-1419. (Pubitemid 38121836)
13. Li DK, Zhao G, Paty DW. T2 hiperintensities: findings and significance. Neuroimaging Clin North Am. 2000; 10: 717-738.
14. Barkhof F, Bruck W, De Groot JG. Remyelinating lesions in Multiple Sclerosis; magnetic resonance image appearance. Arch Neurol. 2003; 60: 1073-1081. (Pubitemid 36975794)
15. Bakshi R, Ariyaratana S, Benedict RH, et al. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol. 2001; 58: 742-748. (Pubitemid 32423046)
16. Schreiber K, Sorensen PS, Koch-Henriksen N, et al. Correlations of brain MRI parameters to disability in multiple sclerosis. Acta Neurol Scand. 2001; 104: 24-30. (Pubitemid 32588396)
17. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler. 1999; 5: 283-286. (Pubitemid 29405626)
18. De Groot JG, Bergers E, Kamphorst W, et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain. 2001; 124: 1635-1645. (Pubitemid 32726776)
19. Lucchinetti CF, Parisi J, Bruck W. The patology of Multiple Sclerosis. In: Wolinsky JS. Neurologic Clinics. Philadelphia: Elsevier Inc; 2005. p. 77-105.
20. Pittock SJ, Lucchinetti CF. The pathology of MS. New insights and potential clinical applications. The Neurologist. 2007; 13 (2): 45-56. (Pubitemid 46398982)
21. nd edition. USA: Elsevier Science; 2002. p. 379-397.
22. Hagmann P, Jonasson L, Maeder P, et al. Understanding Diffusion MR Imaging Techniques: From Scalar Diffusion-Weighted Imaging to Diffusion Tensor Imaging and Beyond. Radiographics. 2006; 26: 205-223.
23. Mukherjee P, Berman JI, Chung SW, et al. Diffusion Tensor MR Imaging and Fiber Tractography: Theoretic Underpinnings. Am J Neuroradiol. 2008; 29: 632-641. (Pubitemid 351571538)
24. Filler A. Magnetic resonance neurography and diffusion tensor imaging: origins, history, and clinical impact of the first 50,000 cases with an assessment of efficacy and utility in a prospective 5000-patient study group. Neurosurgery. 2009; 65 (4 Suppl): A29-A43.
25. Kingsley PB. Introduction to Diffusion Tensor Imaging Mathematics. Concepts in Magnetic Resonance Part A. 2006; 2: 123-154.
26. Padovani A, Borroni B, Brambati SM, et al. Diffusion tensor imaging and voxelbased morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2006; 77: 457-463.
27. Werring DJ, Clark CA, Barker GJ, et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology. 1999; 52: 1626-1632. (Pubitemid 29220638)
28. Vrenken H, Pouwels PJ, Geurts JJ, et al. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging. 2006; 23: 628-636.
29. Droogan AG, Clark CA, Werring DJ, et al. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion weighted imaging. Magn Reson Imaging. 1999; 17: 653-661. (Pubitemid 29247380)
30. Sundgren PC, Dong Q, Gomez-Hassan D, et al. Diffusion Tensor Imaging of the Brain: Review of Clinical Applications. Neuroradiology. 2004; 46: 339-350. (Pubitemid 38787262)
31. Bammer R, Augustin M, Strasser-Fuchs S, et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med. 2000; 44: 583-591.
32. Castriota-Scanderbeg A, Fasano F, Hagberg G, et Al. Coefficient D(av) is more sensitive than fractional anisotropy in monitoring progression of irreversible tissue damage in focal nonactive multiple sclerosis lesions. Am J Neuroradiol. 2003; 24: 663-670. (Pubitemid 36460737)
33. Lazar M, Alexander AL. Bootstrap white matter tractography (BOOT TRAC). Neuroimage. 2005; 24: 524-532. (Pubitemid 41359048)
34. Larsson HB, Thomsen C, Frederiksen J, et al. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging. 1992; 10: 7-12.
35. Filippi M, Iannucci G, Cercignani M, et al. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo plannar imaging. Arch Neurol. 2000; 57: 1017-1021. (Pubitemid 30452507)
36. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996; 111 (3): 209-219. (Pubitemid 126758682)
37. Ciccarelli O, Werring DJ, Wheeler-Kingshott CAM, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology. 2001; 56: 926-933. (Pubitemid 32290810)
38. Roychowdhury S, Maldjian JA, Grossman RI. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. Am J Neuroradiol. 2000; 21: 869-874. (Pubitemid 30262833)
39. Davie CA, Barker GJ, Thompson AJ, et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997; 63: 736-742. (Pubitemid 27520749)
40. Revel M. Interferon-β in the treatment of relapsing-remitting multiple sclerosis. Pharmacol Ther. 2003; 100: 49-62. (Pubitemid 37209942)
41. Kornek B, Storch MK, Weissert R, et al. Multiple Sclerosis and cronic autoimmune encephalomyelitis: a comparative quantative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol. 2000; 157: 267-276. (Pubitemid 30641742)
42. Guo AC, MacFall JR, Provenzale JM. Multiple sclerosis: Diffusion tensor magnetic resonance imaging of normal appearing white matter. Radiology. 2002; 729-735
43. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol. 1992; 18: 319-334.
44. Arnold DL, Matthews PM, Francis GS, et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992; 31: 235-241.
45. Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007; 17 (2): 210-218. (Pubitemid 46466140)
46. Cercignani M, Iannucci G, Rocca MA, et al. 2000. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology. 2000; 54 (5): 1139-1144. (Pubitemid 30151859)
47. Guo AC, MacFall JR, Provenzale JM. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology. 2001; 222 (3): 729-736.
48. Tievsky AL, Ptak T, Farkas J. Investigation af apparent diffusion coefficient and diffusion tensor anisotrophy in acute and cronic multiple sclerosis lesions. Am J Neuroradiol. 1999; 20: 1491-1499. (Pubitemid 29455874)
49. Ceccarelli A, Rocca MA, Falini A, et al. Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol. 2007; 254 (4): 513-518. Epub 2007.
50. Ge Y, Tuvia K, Law M, et al. Corticospinal tract degeneration in brainstem in patients with multiple sclerosis: evaluation with diffusion tensor tractography. In Proceedings: Int Soc. Magn Reson Med (ISMRM), Miami, 2005.
51. nd Annual Meeting of the American Society of Neuroradiology, Seattle, 2005. p. 7.
52. Özakbaş S. Multiple Skleroz'da Özürlülü ǧün Deǧerlendirilmesi Nöropsikiyatri Arşivi. 2008; 45: 6-9.
53. Rovaris M, Rocca MA, Barkhof F, et al. Relationship between MRI lesion load and short-term disease evalution in non-disabiling MS: a large-scale multicentre study. Multiple Sclerosis Journal. 2010; 17 (3): 319-326.
54. Filippi M, Cercignani M, Inglese M, et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology. 2001; 56: 304-311. (Pubitemid 32144139)
55. Goldman MD, Motl RW, Rudick RA. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord. 2010; 3 (4): 229-239.